-
Medicine, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug
-
deciphering their underlying molecular mechanisms in normal developmental processes and tumorigenesis. We cover research areas with relevance to RNA Biology, Cancer Biology, Chromatin Regulation, Cancer
-
epitope selection pipelines. · Experience in molecular virology methods, and antigen presentation and processing as applied to human and murine oncology. · Ability to independently document
-
: · Synthesize small molecules using multi-step processes, modern purification systems (e.g., Flash Chromatography), and advanced analytical tools. · Design and optimize synthetic pathways to efficiently
-
Oncology, JNCI, Clinical Cancer Research, Nature Communications, Nature Reviews Gastroenterology and Hepatology, Annals of Surgery, etc. If you are passionate about some of the following things we
-
and epigenetic regulations and deciphering their underlying molecular mechanisms in normal developmental processes and tumorigenesis. We cover research areas with relevance to RNA Biology, Cancer
-
, shaping the future of medicine through cutting-edge research. Join Dr. Marcel van den Brink’s multidisciplinary team to explore innovative ways to treat malignancies using engineered cellular therapies. We
-
candidate, you will: · You must have experience with flow cytometry, molecular biology techniques, cell culture, microscopy, tissue processing, immunohistochemistry, immunofluorescence, data analysis